Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper chamber. It is a leading cause of stroke from clots that form in a small ...

Patients with atrial fibrillation, or AFib, are at increased risk for stroke.Many of them go on blood thinners, which can cause problems. But there is a relatively new device that is being used ...

NORTH PHILADELPHIA (WPVI) -- Atrial fibrillation is the most common type of irregular heartbeat. And blood thinners are the most common way to deal with the stroke risk of Afib. But a little device ...

Atrial fibrillation is a condition that affects a large number of the population, causing fatigue, shortness of breath, heart palpitations and could eventually lead to stroke. Mercy Health has a safer ...

WILKES-BARRE, PA. (WPVI) -- A few weeks ago, Philadelphia Mayor Jim Kenney had cardiac ablation treatment for atrial fibrillation. There are several other approaches to a-fib, including a device ...

Boston Scientific has obtained an FDA green light for the latest version of its Watchman heart implant, designed to help lower the risk of stroke in patients with atrial fibrillation. Compared to its ...

The Heart Institute of East Texas proudly introduces the latest advancement in cardiac care with the implementation of the Watchman Flx Pro Left Atrial Appendage Occluder implantation technology. This ...

The OPTION trial showed equivalence between Watchman FLX and oral anticoagulation in preventing stroke, systemic embolism, and all-cause death post-ablation. Subgroup analyses revealed consistent ...

SAN FRANCISCO — Thirteen months after percutaneous left atrial appendage closure (LAAC), outcomes did not differ whether closure was performed using the Amulet (Abbott Cardiovascular) or the Watchman ...

February is Heart Health Awareness Month, and a new heart procedure is now available in the Tri-Cities, making it more accessible for local residents.

SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA closure ...